-
-
-
-
-
-
-
Intellia Therapeutics (NTLA) PT Lowered to $29 at Citizens on Nex-Z (ATTR) Risk
-
-
-
-
-
-
-
Intellia Therapeutics to Hold Conference CallĀ to Discuss First Quarter 2025 EarningsĀ and Company Updates
-
-
-
-
-
-
-
Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
-
-
-
-
-
-
-
Intellia Therapeutics (NTLA) Tops Q1 EPS by 26c
-
-
-
-
-
-
-
Intellia Therapeutics (NTLA) Tops Q3 EPS by 12c
-
-
-
-
-
-
-
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2023 Earnings and Company Updates
-
-
-
-
-
-
-
Today's most important downgrades
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

